Tokyo, June 12 -- National Cancer Center Research Institute - Tokyo has issued a Notice of Procurement (Goods & Services) on Jun 11, 2026. Here are other related details:
Classification:
0004 Medical & Pharmaceutical Products
Summary:
⑴ Contracting entity : Hiroyuki Mano, President of National Cancer Center
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased : Unit price contract for test reagents (Central and East) Full set
⑷ Delivery period : From August 1st, 2026 to September 30th, 2026
⑸ Delivey place : National Cancer Center Central&East hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 6 and 7 of the Regulation concerning the Contract for National Cancer Center Research,
B have Grade A, B or C in Sales of products in tenders by Ministry of Health Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Region,
C prove to have prepared a system to provide rapid after-sale service and maintenance for the procured products,
⑺ Time-limit of tender : 5 : 00 P.M. July 22nd, 2026
⑻ Contact point for the notice : Accounting Section, National Cancer Center, 5-1-1 Tsukiji Chuo-ku, Tokyo 104-0045 Japan, TEL +81-3-3547-5201 ext. 2651
Disclaimer: Curated by HT Syndication.
